A regulation shall be applied in its integrality in all the European Union. Unless a directive sets out an objective provided by the European Union, each country is free to develop its own measures to achieve this objective. Figure 1:Overview of the difference between...

Introduction  Nowadays, more and more companies start to grow and lose visibility of the organization’s global landscape. This causes some issues, such as a lack of communication between the sites, work duplication, and a loss of control of the company’s culture...

When FDA applies more advanced technologies to its work, stakeholders can explore new ways of developing FDA-regulated products and new methods of generating data to inform the regulation of those products[i]. — FDA In a letter[ii] to Janet Woodcock, acting...

The quality and safety of a product have always been one of the biggest concerns in the pharmaceutical industry. To address this,  GxP was established and its compliance is mandatory in the healthcare environment. The GxP is a generic term, where ‘G’ stands...